Search InvestCenter

Recent Quotes

My Watchlist

Top Indices

Latest News about NVO

Recent news which mentions NVO

...

21 22 23 24 25 26 27 28 29

...

BioAge Labs Files For $100M IPO, Becomes The New Entrant In Obesity Drugs Race

September 04, 2024

EXCLUSIVE: Vivani Medical Reveals Positive Preclinical Liver Fat Results From Miniature GLP-1 Implant For Obesity

September 04, 2024

Despite Medicare Negotiations, Americans May Still Have To Pay More For Prescription Drugs

September 03, 2024

10 Health Care Stocks With Whale Alerts In Today's Session

September 03, 2024

Eli Lilly Launches Discounted Mounjaro And Zepbound As Fight Against Compounded Imitations Escalates Amid Ongoing FDA Shortage Status Debate

September 02, 2024

Ozempic: Unexpected Anti-Aging Miracle Drug? Researchers Reveal Surprising Potential

August 31, 2024

3 No-Brainer Stocks to Buy in September

August 31, 2024

These 3 Factors Could Make Eli Lilly Stock a Better Buy Than Novo Nordisk Right Now

August 31, 2024

Judge's Early Ruling May Shape Outcome In Ozempic, Wegovy Lawsuits

August 30, 2024

Novo Nordisk Touts Encouraging Wegovy Data To Lower Risk Of Severe Complications In Heart Failure Patients

August 30, 2024

This New Finding About Ozempic and Wegovy Could Hurt Novo Nordisk's Stock

August 30, 2024

Is Eli Lilly Stock a No-Brainer Buy After the Company's Brilliant Zepbound Move?

August 29, 2024

Eli Lilly Is The Nvidia Of Weight Loss And GLP-1 Space, Says Roundhill Investments CEO, Emphasizes Market Leadership And Growth Potential Of Zepbound Maker

August 28, 2024

Looking At Novo Nordisk's Recent Unusual Options Activity

August 27, 2024

Ozempic Could Have a Terrible Side Effect. Is Novo Nordisk in Trouble?

August 27, 2024

Governments Suing Pharmacy Benefit Managers Over Insulin Prices Have Long Benefited From Their Rebates

August 26, 2024

Novo Nordisk Does Not Operate As Drug Cartel, CEO Defends US Pricing Of Ozempic Against Criticism Over High Drug Prices

August 26, 2024

This GLP-1 Biotech Stock Could Give Novo Nordisk a Run for Its Money

August 25, 2024

2 No-Brainer Healthcare Stocks to Buy With $1,000

August 24, 2024

Novo Nordisk's Ozempic Might Be Among 2027 Medicare Price Negotiation Targets

August 23, 2024

These Were the Top-Selling GLP-1 Drugs Last Quarter From Eli Lilly and Novo Nordisk

August 23, 2024

Forget Novo Nordisk: Buy This Magnificent Pharma Stock Instead

August 23, 2024

What the Options Market Tells Us About Novo Nordisk

August 22, 2024

Wegovy Now Available Through Sesame's $249 Monthly Compounded Program Despite Supply Shortages

August 21, 2024

Novo Nordisk Vs. Eli Lilly: Beyond The Weight-Loss Drug Battle

August 21, 2024

Eli Lilly Stock Could Soar to $1,150, According to a Wall Street Analyst. Is It a Buy at Around $945?

August 21, 2024

Ozempic And Wegovy Linked to Increased Suicidal Thoughts In Observational Study, But Results Are Contested

August 20, 2024

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $5,900 Today

August 20, 2024

Soviet Code Breaker Jim Simons' Hedge Fund Renaissance Technologies — Ozempic, Wegovy Maker Novo Nordisk Along With Nvidia, Palantir Among Top Holdings

August 19, 2024

A Glimpse Into The Expert Outlook On Novo Nordisk Through 8 Analysts

August 19, 2024

...

21 22 23 24 25 26 27 28 29

...

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.

© 2025 FinancialContent. All rights reserved.